It has been speculated that PSMA expression solely on the neovasculature could result in a shortened tracer washout [53, 94], meaning that PSMA-RLT is not retained in the tumor for a longer time, resulting in a lower radiation dose to the tumor and less effective treatment. This evidence concerns the gene FOLH1 and neoplasm.